Denali Therapeutics Inc (DNLI)
Investing Cash Flow
$68.98M
TTM · Period ending: · USD
DNLI Investing Cash Flow
Latest reported$68.98Mperiod ending
Latest reported$68.98Mperiod ending
DNLI TTM Cash from Investing (-$219.00M → $68.98M)
TTM investing cash flow
High-resolution chart · PNG
DNLI investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 68,980,000 | |
| 330,993,000 | |
| 255,281,000 | |
| 406,720,000 | |
| 442,545,000 | |
| 383,179,000 | |
| -88,756,000 | |
| -187,916,000 | |
| -180,662,000 | |
| -111,164,000 | |
| 249,308,000 | |
| 48,702,000 | |
| -36,788,000 | |
| -116,224,000 | |
| -141,387,000 | |
| -54,578,000 | |
| -123,005,000 | |
| -114,099,000 | |
| -21,626,000 | |
| -348,216,000 | |
| -507,330,000 | |
| -635,278,000 | |
| -623,206,000 | |
| -213,481,000 | |
| 48,134,000 | |
| 142,426,000 | |
| 147,712,000 | |
| 43,924,000 | |
| 39,158,000 | |
| 5,805,000 | |
| -287,422,000 | |
| -321,168,000 | |
| -349,369,000 | |
| -357,823,000 | |
| -41,166,000 | |
| 35,036,000 | |
| -130,798,000 | |
| -178,246,500 | |
| -219,004,000 |